Skip to main content

Table 3 Prevalence of sarcopenia and sarcopenia categories according to BIS eGFR (ml/min/1.73m2) categories

From: Prevalence of sarcopenia in community-dwelling older adults using the updated EWGSOP2 definition according to kidney function and albuminuria

  Non-sarcopenic (n = 1270) Sarcopenic (n = 150) p-value
BIS eGFR category No sarcopenia (n = 1114) Probable sarcopenia (n = 156) Confirmed sarcopenia (n = 65) Severe sarcopenia (n = 85)
≥90 (n = 9) 6 (66.7%) 3 (33.3%) 0.026
3 (33.3%) 3 (33.3%) 2 (22.2%) 1 (11.1%)  
60–89 (n = 538) 483 (89.8%) 55 (10.2%) 0.745
440 (81.8%) 43 (8.0%) 26 (4.8%) 29 (5.4%)  
45–59 (n = 542) 496 (91.5%) 46 (8.5%) 0.046
436 (80.4%) 60 (11.1%) 25 (4.6%) 21 (3.9%)  
30–44 (n = 259) 225 (86.9%) 34 (13.1%) 0.138
188 (72.6%) 37 (14.3%) 10 (3.9%) 24 (9.3%)  
15–29 (n = 72) 60 (83.3%) 12 (16.7%) 0.084
47 (65.3%) 13 (18.1%) 2 (2.8%) 10 (13.9%)  
≥60 (n = 1089) 985 (90.4%) 104 (9.6%) 0.024
879 (80.7%) 106 (9.7%) 53 (4.9%) 51 (4.7%)
< 60 (n = 331) 285 (86.1%) 46 (13.9%)
235 (71.0%) 50 (15.1%) 12 (3.6%) 34 (10.3%)
  1. BIS Berlin Initiative Study, eGFR Estimated glomerular filtration rate